Rita Jain

Dr. Rita I.
Jain, MD, is an Independent Director at SAB Biotherapeutics, Inc., an Independent Director at Avalo Therapeutics, Inc., an Independent Director at Celldex Therapeutics, Inc. and an Independent Director at First Tracks Biotherapeutics, Inc. She is on the Board of Directors at SAB Biotherapeutics, Inc., Avalo Therapeutics, Inc., Celldex Therapeutics, Inc. and First Tracks Biotherapeutics, Inc. Dr. Jain was previously employed as an Independent Director by AnaptysBio, Inc., a Chief Medical Officer & Senior Vice President by Immunovant, Inc., a Member-Supervisory Board by AM-Pharma Holding BV, a Member-Supervisory Board by AM-Pharma BV, a Chief Medical Officer, Executive Director & EVP by ChemoCentryx, Inc., a Chief Medical Officer & Senior Vice President by Akebia Therapeutics, Inc., a Vice President-Health & Metabolic Development by AbbVie, Inc., a Vice President-Pharmaceutical Development by Abbott Laboratories, an Assistant Professor by New York University School of Medicine, and a Member by North Shore University Hospital.
She also served on the board at Provention Bio, Inc. She received her undergraduate degree from Long Island University and a doctorate degree from Stony Brook University School of Medicine.